title: HTLV-I Tax-Mediated Inactivation of Cell Cycle Checkpoints and DNA Repair Pathways Contribute to Cellular Transformation: "A Random Mutagenesis Model".
abstract: To achieve cellular transformation, most oncogenic retroviruses use transduction by proto-oncogene capture or insertional mutagenesis, whereby provirus integration disrupts expression of tumor suppressors or proto-oncogenes. In contrast, the Human T-cell leukemia virus type 1 (HTLV-I) has been classified in a separate class referred to as "transactivating retroviruses". Current views suggest that the viral encoded Tax protein transactivates expression of cellular genes leading to deregulated growth and transformation. However, if Tax-mediated transactivation was indeed sufficient for cellular transformation, a fairly high frequency of infected cells would eventually become transformed. In contrast, the frequency of transformation by HTLV-I is very low, likely less than 5%. This review will discuss the current understanding and recent discoveries highlighting critical functions of Tax in cellular transformation. HTLV-I Tax carries out essential functions in order to override cell cycle checkpoints and deregulate cellular division. In addition, Tax expression is associated with increased DNA damage and genome instability. Since Tax can inhibit multiple DNA repair pathways and stimulate unfaithful DNA repair or bypass checkpoints, these processes allow accumulation of genetic mutations in the host genome. Given this, a "Random Mutagenesis" transformation model seems more suitable to characterize the oncogenic activities of HTLV-I.
authors.affiliation: Department of Pathology and Laboratory Medicine, Center for Viral Oncology, University of Kansas Medical Center, USA.
authors.forename: Christophe
authors.initials: C
authors.lastname: Nicot
references.citation: J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S162-9
references.pmid: 8797719
references.citation: Genome Biol. 2014;15(6):122
references.pmid: 25180339
references.citation: Curr Top Microbiol Immunol. 1990;160:121-8
references.pmid: 2191838
references.citation: J Virol. 2010 May;84(10):5431-7
references.pmid: 20219913
references.citation: Int J Cancer. 2008 Jan 15;122(2):305-16
references.pmid: 17918160
references.citation: Nature. 1989 Sep 7;341(6237):72-4
references.pmid: 2788824
references.citation: J Biol Chem. 1997 Sep 26;272(39):24522-9
references.pmid: 9305916
references.citation: J Virol. 1999 May;73(5):4299-304
references.pmid: 10196328
references.citation: Blood. 1992 Jan 15;79(2):477-80
references.pmid: 1730092
references.citation: J Biol Chem. 2008 Dec 26;283(52):36311-20
references.pmid: 18957425
references.citation: Oncogene. 2006 Aug 28;25(38):5220-7
references.pmid: 16936740
references.citation: J Biol Chem. 1998 Sep 4;273(36):23598-604
references.pmid: 9722600
references.citation: Cancer Res. 1994 Mar 1;54(5):1169-74
references.pmid: 8118801
references.citation: J Biol Chem. 1995 Dec 1;270(48):28503-6
references.pmid: 7499359
references.citation: Oncogene. 2005 Jan 20;24(4):525-40
references.pmid: 15580311
references.citation: J Exp Med. 2014 Dec 15;211(13):2497-505
references.pmid: 25488980
references.citation: J Clin Invest. 1991 Sep;88(3):1038-42
references.pmid: 1832173
references.citation: Cancer Sci. 2006 Sep;97(9):836-41
references.pmid: 16805820
references.citation: Blood. 2010 Mar 25;115(12):2441-8
references.pmid: 20093405
references.citation: J Virol. 2001 Mar;75(5):2161-73
references.pmid: 11160720
references.citation: J Natl Cancer Inst. 1999 Jun 2;91(11):933-42
references.pmid: 10359545
references.citation: Nucleic Acids Res. 2004 Jul 13;32(12):3683-8
references.pmid: 15252152
references.citation: Mol Cancer. 2007 Apr 02;6:24
references.pmid: 17407548
references.citation: Mol Cell Biol. 2003 Aug;23 (15):5269-81
references.pmid: 12861013
references.citation: Neoplasia. 2015 May;17(5):449-62
references.pmid: 26025667
references.citation: Biochemistry (Mosc). 2011 Jan;76(1):24-35
references.pmid: 21568837
references.citation: Proc Natl Acad Sci U S A. 1982 Mar;79(6):2031-5
references.pmid: 6979048
references.citation: EMBO J. 1996 Feb 15;15(4):873-87
references.pmid: 8631308
references.citation: Mol Biol Cell. 1995 Apr;6(4):387-400
references.pmid: 7626805
references.citation: Blood. 2006 Aug 1;108(3):1021-9
references.pmid: 16569765
references.citation: Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9
references.pmid: 6261256
references.citation: Blood. 2014 Jun 19;123(25):3925-31
references.pmid: 24735963
references.citation: Cancer Res. 2014 Nov 1;74(21):6082-93
references.pmid: 25205102
references.citation: Carcinogenesis. 1997 Apr;18(4):605-10
references.pmid: 9111189
references.citation: PLoS One. 2014 Feb 21;9(2):e89390
references.pmid: 24586743
references.citation: Genes Dev. 2002 Sep 1;16(17 ):2179-206
references.pmid: 12208841
references.citation: Mol Cancer. 2009 Feb 13;8:8
references.pmid: 19216791
references.citation: AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1623-7
references.pmid: 11080801
references.citation: Leuk Lymphoma. 1998 Mar;29(1-2):27-35
references.pmid: 9638973
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):720-5
references.pmid: 16407133
references.citation: Adv Cancer Res. 2003;89:69-132
references.pmid: 14587871
references.citation: Neurology. 1991 Feb;41(2 ( Pt 1)):192-7
references.pmid: 1992361
references.citation: PLoS One. 2012;7(8):e42226
references.pmid: 22916124
references.citation: Virology. 1999 Jan 20;253(2):155-61
references.pmid: 9918874
references.citation: Mutat Res. 2009 Oct 2;669(1-2):8-12
references.pmid: 19576233
references.citation: J Virol. 2008 Dec;82(23):11714-22
references.pmid: 18799587
references.citation: Curr Top Microbiol Immunol. 1998;227:25-41
references.pmid: 9479824
references.citation: Virology. 1999 Jul 5;259(2):384-91
references.pmid: 10388662
references.citation: Mol Cancer. 2010 Nov 23;9:302
references.pmid: 21092281
references.citation: Mol Cancer. 2007 Apr 02;6:26
references.pmid: 17407576
references.citation: Nat Cell Biol. 2006 Jul;8(7):717-24
references.pmid: 16767081
references.citation: Carcinogenesis. 2006 Apr;27(4):673-81
references.pmid: 16308315
references.citation: J Biol Chem. 2000 Apr 14;275(15):11154-63
references.pmid: 10753922
references.citation: Oncogene. 2013 Sep 5;32(36):4222-30
references.pmid: 23045287
references.citation: Pharmacol Ther. 1980;9(2):147-70
references.pmid: 6157165
references.citation: Blood. 2011 Mar 17;117(11):3113-22
references.pmid: 21228324
references.citation: Oncogene. 1996 Apr 18;12(8):1645-52
references.pmid: 8622884
references.citation: Blood. 2011 Jun 2;117(22):5897-906
references.pmid: 21427292
references.citation: Blood. 2011 Oct 6;118(14):3911-21
references.pmid: 21821710
references.citation: Cancer Lett. 2005 Dec 8;230(1):6-19
references.pmid: 16253756
references.citation: Blood. 1996 Sep 1;88(5):1551-60
references.pmid: 8781409
references.citation: Curr Top Microbiol Immunol. 1991;171:1-25
references.pmid: 1814689
references.citation: EMBO J. 2006 Apr 19;25(8):1741-52
references.pmid: 16601696
references.citation: Mol Cell Biol. 1990 Jan;10(1):413-7
references.pmid: 2403646
references.citation: Cancer Surv. 1997;29:7-23
references.pmid: 9338094
references.citation: Biochem Pharmacol. 2012 Jul 15;84(2):137-46
references.pmid: 22469522
references.citation: Mol Cancer. 2014 Sep 04;13:205
references.pmid: 25185513
references.citation: J Biol Chem. 2007 Jun 1;282(22):16441-53
references.pmid: 17428792
references.citation: Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):63-8
references.pmid: 15623561
references.citation: Blood. 1995 May 15;85(10):2699-704
references.pmid: 7742529
references.citation: PLoS One. 2013;8(2):e55989
references.pmid: 23405243
references.citation: Oncogene. 2001 Apr 19;20(17):2055-67
references.pmid: 11360190
references.citation: Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):18974-9
references.pmid: 16365316
references.citation: Rev Clin Exp Hematol. 2003 Dec;7(4):336-61
references.pmid: 15129647
references.citation: Nat Rev Cancer. 2007 Nov;7(11):861-9
references.pmid: 17943134
references.citation: Leukemia. 1995 Apr;9(4):598-604
references.pmid: 7723391
references.citation: J Cell Sci. 2001 Mar;114(Pt 5):953-63
references.pmid: 11181178
references.citation: J Biol Chem. 2000 Nov 24;275(47):36498-501
references.pmid: 11005803
references.citation: Am J Hematol. 2005 Feb;78(2):100-7
references.pmid: 15682421
references.citation: Blood. 2012 Jan 5;119(1):151-60
references.pmid: 22058115
references.citation: J Virol. 1998 Nov;72(11):8852-60
references.pmid: 9765430
references.citation: Oncogene. 1999 Apr 15;18(15):2441-50
references.pmid: 10229195
references.citation: J Virol. 2008 Jul;82(14):6952-61
references.pmid: 18434398
references.citation: Oncogene. 2003 Aug 11;22(33):5131-40
references.pmid: 12910250
references.citation: J Virol. 2000 Aug;74(16):7270-83
references.pmid: 10906181
references.citation: Blood. 2000 Jun 15;95(12 ):3939-44
references.pmid: 10845931
references.citation: Nucleic Acids Res. 2008 Jul;36(12 ):4088-98
references.pmid: 18539610
references.citation: Virology. 2011 Jul 20;416(1-2):1-8
references.pmid: 21571351
references.citation: J Virol. 1998 Feb;72(2):1165-70
references.pmid: 9445014
references.citation: Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16619-24
references.pmid: 20823234
references.citation: Mol Cancer. 2014 Nov 18;13:249
references.pmid: 25404525